SCHEMBL8550985

SCHEMBL8550985

CCCOC1CNCCN1c1ccccc1

nearest known ligand 0.50

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SLC6A2 P23975 7/20 0.50
SLC6A4 P31645 7/20 0.50
SLC6A3 Q01959 7/20 0.50
HTR2C P28335 7/20 0.41
HTR2B P41595 6/20 0.41
HTR2A P28223 5/20 0.41
ADRB1 P08588 3/20 0.41
HTR3E A5X5Y0 1/20 0.38
HTR3B O95264 1/20 0.38
HTR3A P46098 1/20 0.38
HTR3D Q70Z44 1/20 0.38
HTR3C Q8WXA8 1/20 0.38
SIGMAR1 Q99720 1/20 0.38
KCNH2 Q12809 1/20 0.36
CYP2D6 P10635 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8780409 0.89 SLC6A2 (0.46) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL2721007 0.88 SLC6A2 (0.52) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL644545 0.82 SLC6A2 (0.54) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
Hydrochloric Acid SCHEMBL5793498 0.80 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
Bromide SCHEMBL27797303 0.80 SLC6A2 (0.53) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL5037533 0.80 SLC6A2 (0.50) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL5506036 0.77 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
Bicarbonate SCHEMBL11620060 0.77 SLC6A2 (0.49) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL15974677 0.76 SLC6A2 (0.51) SLC6A2SLC6A4SLC6A3HTR2CHTR2B
SCHEMBL11267479 0.75 SLC6A2 (0.66) SLC6A2SLC6A4SLC6A3ADRB1HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0836599-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1998-04-22 EP disclosed
US-5322846-A Useful in treatment of cardiovascular diseases associated with hyperactivity of the sympathetic nervous system INSTITUT DE RECHERCHES CHIMIQUES ET BIOLOGIQUES APPLIQUEES (I.R.C.E.B.A.) (FR) 1994-06-21 US disclosed